Jianxin Pang

Prof. Dr. Jianxin Pang

Guangdong Provincial Key Laboratory of Drug Screening, School of Pharmaceutical Sciences, Southern Medical University

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2021 in Phytomedicine
Verified
Journal Article
Closed access
YLYongmei Li
Yongmei Li
ZZZean Zhao
Zean Zhao
JLJian Luo
Jian Luo
YJYanqing Jiang
Yanqing Jiang
LLLu Li
Lu Li
JPJianxin Pang
Jianxin Pang

1 January 2021 in Phytomedicine
Verified
Journal Article
Closed access
YCYanyu Chen
Yanyu Chen
ZZZean Zhao
Zean Zhao
YLYongmei Li
Yongmei Li
YYYang Yang
Yang Yang
LLLu Li
Lu Li
JPJianxin Pang
Jianxin Pang

8 September 2020 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
TZTong Zhao
Tong Zhao
QMQing Meng
Qing Meng
ZSZhuosen Sun
Zhuosen Sun
YCYanyu Chen
Yanyu Chen
WAWei Ai
Wei Ai
Peng ZhanPeng Zhan
Peng Zhan

25 March 2021 in Acta Pharmacologica Sinica
Verified
Journal Article
Closed access
PDF file
ZZZe-An Zhao
Ze-An Zhao
YJYu Jiang
Yu Jiang
YCYan-Yu Chen
Yan-Yu Chen
TWTing Wu
Ting Wu
QLQun-Sheng Lan
Qun-Sheng Lan
JPJianxin Pang
Jianxin Pang

2 November 2022 in Foods
Verified
Journal Article
Open access
PDF file
YLYongmei Li
Yongmei Li
LLLu Li
Lu Li
JTJinhong Tian
Jinhong Tian
FZFengxin Zheng
Fengxin Zheng
HLHui Liao
Hui Liao
TWTing Wu
Ting Wu
Hyperuricemia (HUA), characterized by abnormal serum uric acid (UA) levels, is recognized as an important risk factor for hyperuricemic nephropathy (HN), which is strongly linked to gut microbiota. This study investigated the protective effects and regulatory mechanisms of insoluble fiber from barley leaves (BL) against HN, induced by adenine (Ad) and potassium oxonate (PO). The results showed that BL dramatically reduced the levels of serum UA and creatinine (CR) and alleviated renal injury and fibrosis. Moreover, BL modulated oxidative stress and downregulated the expression of urate transporter 1 (URAT1) and glucose transporter 9 (GLUT9) in the kidneys of mice with HN. In addition, the 16S rRNA sequence data showed that BL also increased the relative abundance of short-chain fatty acids (SCFAs)-producing bacteria, including Bacteroides, Alloprevotella, and Eisenbergiella. Besides, BL treatment also increased SCFAs levels. Of interest, the application of SCFAs in hyperuricemic mice effectively reduced their serum UA. Furthermore, SCFAs dose-dependently inhibited URAT1 and GLUT9 in vitro and potently interacted with URAT1 and GLUT9 in the docking analysis. When taken together, our results indicate that BL and its metabolite SCFAs may be potential candidates for relieving HUA or HN.

8 November 2024 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
ZSZhiqiang Sun
Zhiqiang Sun
XZXuewen Zhang
Xuewen Zhang
ZZZean Zhao
Zean Zhao
XLXiaoxun Li
Xiaoxun Li
JPJianxin Pang
Jianxin Pang
JCJianjun Chen
Jianjun Chen